Sands Capital Life Sciences Pulse Fund II, L.P.

Insider Reports History

Entity
Company
Location
C/O Sands Capital Ventures, Llc, 1000 Wilson Boulevard, Suite 3000, Arlington, VA
Signature
Sands Capital Life Sciences Pulse Fund II, L.P., By: Sands Capital Life Sciences Pulse Fund II-GP, L.P., its General Partner, By: Sands Capital Life Sciences Pulse Fund II-GP, LLC, its General Partner, By: /s/ Jonathan Goodman, General Counsel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sands Capital Life Sciences Pulse Fund II, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. 10%+ Owner Common Stock 11M $15M $1.37 Oct 21, 2024 Direct

Insider Reports Filed by Sands Capital Life Sciences Pulse Fund II, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Oct 21, 2024 0 $0 3 Oct 25, 2024 10%+ Owner